| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9518 |
| Human Intestinal Absorption | HIA- | 0.9477 |
| Caco-2 Permeability | Caco2- | 0.8422 |
| P-glycoprotein Substrate | Non-substrate | 0.8100 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9491 |
| Non-inhibitor | 0.9675 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9541 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7557 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8034 |
| CYP450 2D6 Substrate | Non-substrate | 0.8493 |
| CYP450 3A4 Substrate | Non-substrate | 0.7389 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9279 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9272 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9062 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9365 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9741 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9111 |
| Non-inhibitor | 0.9519 |
| AMES Toxicity | Non AMES toxic | 0.8874 |
| Carcinogens | Carcinogens | 0.5815 |
| Fish Toxicity | Low FHMT | 0.7026 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6969 |
| Honey Bee Toxicity | High HBT | 0.7868 |
| Biodegradation | Not ready biodegradable | 0.7265 |
| Acute Oral Toxicity | III | 0.7765 |
| Carcinogenicity (Three-class) | Non-required | 0.5979 |